Common Contracts
4 similar null contracts by Medite Cancer Diagnostics, Inc.
12% SECURED CONVERTIBLE NOTEMedite Cancer Diagnostics, Inc. • July 13th, 2018 • Surgical & medical instruments & apparatus • New York
THIS 12% SECURED CONVERTIBLE NOTE is issued by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).
12% SECURED CONVERTIBLE NOTEMedite Cancer Diagnostics, Inc. • February 12th, 2018 • Surgical & medical instruments & apparatus • New York
THIS 12% SECURED CONVERTIBLE NOTE is issued by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Medite Cancer Diagnostics, Inc. • October 2nd, 2017 • Surgical & medical instruments & apparatus • New York
THIS 13.25% SECURED CONVERTIBLE NOTE is issued at a 2.5% original issue discount by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Medite Cancer Diagnostics, Inc. • October 2nd, 2017 • Surgical & medical instruments & apparatus • New York
THIS 13.25% SENIOR SECURED CONVERTIBLE NOTE is issued at an 9.9% original issue discount by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).
